Chicago Atlantic Real Estate Finance, Inc. (REFI) Earnings Call Transcript & Summary
November 4, 2025
Earnings Call Speaker Segments
Tripp Sullivan
executiveThanks, and good morning everyone. It's great to have you join Chicago Atlantic Real Estate Finance's call, where we'll go over what the company achieved. Joining us are Peter Sack, our Co-Chief Executive Officer, David Kite, our Chief Operating Officer, and Phil Silverman, our Chief Financial Officer. Earlier today, our numbers went out through the earnings press release, and you can locate it in the Investor Relations area of our site, together with the supplemental we filed with the SEC. A live audio webcast is available for today's session. If you're tuning in to the replay afterward, please note that anything said here reflects only today and won't be revised after this call ends. Throughout this call, some of our comments and statements might fall under the definition of forward-looking statements per the securities laws, covering things like how our portfolio will perform going forward, our pipeline of possible loans and other investments, upcoming dividends, and financing activities. Every forward-looking statement reflects Chicago Atlantic's judgment as of today's conference call date, and carries risks and uncertainties that could make actual outcomes differ materially from what we now expect. We encourage investors to thoroughly examine the various disclosures the company makes, including the risk and other details in the company's SEC filings. We'll also touch on certain non-GAAP measures, such as distributable earnings among others. You can find definitions of these non-GAAP measures, plus reconciliations to the closest comparable GAAP measures, in our SEC filings. At this point, I'll hand things over to Peter Sack. Go ahead, please.
Peter Sack
executiveThanks, Tripp. Morning, all. During this quarter, while private credit conditions stayed turbulent, we showed once again that we can execute and perform consistently. Our steady strategy and careful emphasis on safeguarding principal produced a solid quarter, and gross originations for the period put us on track to achieve our target of net growth in the loan portfolio. Turmoil in private credit markets has sparked fresh anxiety among investors. Falling interest rates hurt lenders holding floating-rate portfolios. The syndicated loan space saw prominent fraud-related collapses, and surplus capital circulating in the market fuels a sense that underwriting standards have weakened. My guess is that these wider worries have led our shares to trade at a meaningful discount to book value, instead of the premium we enjoyed for so long after our IPO almost 4 years back. Seeing this gap between market perception and the actual state of our portfolio, our management team and board of directors bought shares on the open market in recent weeks, which lifted our combined ownership of common stock to roughly 1.8 million shares on a fully diluted basis. Multiple factors explain why we hold such conviction in what we've built at Chicago Atlantic. First, our cannabis pipeline right now sits at about $441 million. In our view, this set of opportunities has no equal within the industry, and it spans growth investments, maturities in the market, M&A activity tied to operational and balance sheet restructurings, and possible ESOP sale transactions. Second, we possess the strongest platform and capital base to support the industry's expansion. We put capital to work alongside consumer and product-focused operators in limited-licensed jurisdictions, using low-leverage profiles, to back fundamentally sound growth initiatives. I struggle to find a finer illustration of our dedication to this industry than Chicago Atlantic's funding this quarter of what we consider the biggest real estate-backed revolving credit facility among U.S. operators in the industry's history, a $75 million three-year secured revolver with Verano. Finally, we've built a portfolio whose risk-return profile is differentiated and low-leverage, insulating it from both cannabis equity and interest rate swings. As David will explain shortly, since we structured our floating loans with interest rate floors, only about 14% of our total loan portfolio faces exposure to any additional rate decreases, using today's 7% prime rate as the baseline. That discipline gives the portfolio a meaningful degree of protection. Our aim is to outperform and deliver the returns all of us expect as shareholders. Having confidence in the strategy matters, and I hope I've shed some light on why we feel enthusiastic and why we, as a management team, carried out share repurchases in recent weeks; but executing our plan matters even more, and I'm eager to report on our continued progress through the rest of the year. David, over to you.
David Kite
executiveThanks, Peter. At September 30, the principal balance of our loan portfolio came to roughly $400 million spread over 26 portfolio companies, and the weighted average yield to maturity stood at 16.5%, versus 16.8% in the second quarter. Gross originations for the quarter reached $39.5 million in principal fundings, including $11 million funded to a new borrower and $20 million tied to the new Verano credit facility that Peter referenced earlier. Offsetting those were unscheduled principal repayments totaling $62.7 million, which we disclosed last quarter. At September 30, 2025, fixed-rate loans made up 36.7% of our portfolio, while floating-rate loans accounted for 63.3%. The floating-rate slice is mostly tied to the prime rate. After last week's 25 basis point cut, which brought prime to 7%, just 14% of our portfolio still faces exposure to additional rate decreases. The other 86% is either fixed-rate or shielded by primary floors at 7% or above. Notably, interest rate caps pose no exposure to our floating-rate loans. That structural edge, paired with our rate floor protections, puts our portfolio in a favorable spot relative to most mortgage REITs. If the Federal Reserve makes another change to the Fed funds target in December, we are well protected from the negative impact of falling interest rates. Total leverage was 33% of book equity at September 30, versus 39% at June 30. At September 30, we had $52.4 million drawn on our senior secured revolving credit facility and $49.3 million drawn on our unsecured term loan. As of today, roughly $69.1 million is available on the senior credit facility, along with total liquidity, net of estimated liabilities, of approximately $63 million. I'll hand it over to Phil now.
Phil Silverman
executiveThank you, David. For the third quarter, net interest income came in at $13.7 million, which was down 5.1% versus the $14.4 million we recorded in Q2 2025. What drove that decline was mostly non-recurring fees from prepayments, make-wholes, exits, and structuring, totaling $1.1 million in Q3 2025, versus $1.5 million in Q2 2025. On top of that, roughly $0.1 million of the drop in net interest income came from the 25 basis point rate cut that landed late in September, affecting our floating-rate portfolio along with interest expense tied to our revolving credit facility. Interest expense overall, which includes non-cash amortization of financing costs, came to about $1.6 million in Q3, lower than the $2.1 million recorded in Q2. Weighted average borrowings under our revolving loan fell by $14 million, compared to $42.3 million in Q2. As of September 30, 2025, our CECL reserve against loans held for investment stood at roughly $5 million, versus $4.4 million at June 30. Relative to size, that expected credit loss reserve works out to about 1.25% of the outstanding principal on loans held for investment. Looking at weighted averages, the portfolio keeps solid real estate coverage at 1.2 times. Beyond real estate, our loans are backed by other collateral types, such as UCC-1 all-asset liens against borrower credit parties. Those additional collateral forms help support overall credit quality and bring loan-to-value ratios down. As of September 30, our portfolio's weighted average loan-to-enterprise value ratio was 43.5%, figured as the borrower's senior indebtedness divided by enterprise value. For Q3, distributable earnings per weighted average share came to roughly $0.50 basic and $0.49 fully diluted, a small step down from $0.52 and $0.51, respectively, in Q2. In October, we paid out the third-quarter dividend of $0.47 per common share that our board declared back in September. Book value per common share outstanding stood at $14.71 as of September 30, 2025, with about 21.5 million common shares outstanding on a fully diluted basis at that date. We still anticipate keeping a dividend payout ratio of 90%-100% for the 2025 tax year, based on basic distributable earnings per share. Should our taxable income call for distributions beyond the regular quarterly dividend to satisfy taxable income requirements, we'd expect to handle that through a special dividend in Q4. Operator, we're ready for questions now.
Aaron Grey
analystHello, and good morning. I really appreciate you taking these questions. For my first one, I'd like to discuss the pipeline a bit. So, $415 million — I realize that's somewhat lower than what we saw in earlier quarters. I just wanted to explore whether any sizable prospective originations left the pipeline. Also, I recall that during the previous quarter you mentioned ESOPs and the possible opportunity they present. So I was hoping to find out whether you still consider those attractive and part of what's in the pipeline. Thank you.
Peter Sack
executiveYes. ESOPs remain a big component of what's in the pipeline. Nothing major dropped out apart from the usual rotation that happens with our pipeline from one quarter to the next. Roughly each quarter, our pipeline gets refreshed as deals either fall away, are rejected by us, or end up funded; so the shifts from quarter to quarter are just normal churn.
Aaron Grey
analystAll right, that's good to hear — ESOPs remain a solid opportunity for you folks, it sounds like. My second question relates to those loans coming due before the year is out — is there anything you can share about how those discussions are going? I realize you're still aiming for net portfolio growth this year, so any detail on that front would be very much appreciated.
Peter Sack
executiveRight now we're working through the terms on which we might extend so as to keep the business and hold onto the position, and my expectation is that for the great majority of those loans maturing prior to year-end, we'll keep them in one form or another.
Aaron Grey
analystAll right, that's wonderful to learn. One final thing from my side. There aren't any direct consequences for fresh cannabis legalization from today's election, though a few are indirect, especially in Virginia, should a different administration take office that favors cannabis more strongly. Looking specifically at that state, I realize additional states becoming active might present a solid chance for you folks; so in what ways might you consider a state such as Virginia regarding the possibilities available there, plus how the current regulatory situation stands and what it might become tomorrow, drawing on earlier laws about retail establishment? Thanks.
Peter Sack
executiveIn our view, Virginia represents a highly appealing medical marketplace. This stems from its tightly regulated licensing framework and the manner in which the regulator arranged the geographic placement of those holding licenses. We also believe it will become a tremendously appealing adult-use market. Consequently, as those talks move forward, we'll aim to grow our connections within the state and put capital to work.
Aaron Grey
analystAll right, sounds good. I appreciate the update. I'll go ahead and get in line now.
Peter Sack
executiveAppreciate it, Aaron.
Chris Muller
analystCongratulations on yet another strong quarter. You all have performed really well when it comes to underwriting in what is a fairly difficult segment of the market. Could you all describe your method for underwriting and what is behind that achievement? Is it primarily the kinds of borrowers you target, the locations, or perhaps some mix of both?
Peter Sack
executiveYes, I believe you have identified a few of the main points. First, I think the basis for how we underwrite is an evaluation of every individual market. Every one of those markets across the 40 states where medical or recreational cannabis has been legalized, and that evaluation starts before a single dollar has been put to work in that market. And it is not merely a matter of concentrating on the state. It is also a more thorough examination of every component of the supply chain in that market. We concentrate on jurisdictions with limited licenses because we have found that in such places the regulatory moat produces more reliable wholesale prices, margins, and competitive conditions. Inside that structure, we concentrate on operators that have varied sources of earnings, whether those earnings come from a varied set of retail operations, retail plus vertical integration, or retail vertical integration distributed across several limited license states.
Chris Muller
analystUnderstood. All of that is quite useful, I suppose.
Peter Sack
executiveAnd finally, beyond real estate collateral — sorry, in addition to that — our lending targets operators, and we do so at conservative leverage, below two times EBITDA. Honestly, when you put all those elements together, you get diversity in how repayment can happen. Diversity in where growth might come from. And while we're putting loans together, I believe it matters that with most of our loans, our capital isn't just funding growth efforts that lift EBITDA. Most of our loans also carry amortization. So the goal is this: by the time they mature, our loans should carry less risk than they did initially, thanks to EBITDA growth plus pay down of the loan, and we can keep backing those clients into their next stage of growth, be it acquisitions, more cultivation, or more retail. And really, it's just staying consistent with an approach to this industry that we consider fairly simple fundamentals — credit quality first, principal protection first — and that's what has let us keep up the track record amid substantial volatility in equity valuations and in the marketplaces, the operating marketplaces, in every one of these states.
Chris Muller
analystUnderstood. That is extremely useful. And perhaps if we take a slight forward-looking view; examining the loan-to-value ratios across your book. Those sit far under what typically applies to a standard commercial mortgage rate. So should we ultimately receive some form of reform, be it during this year, the following year, or at whatever point that occurs. What kind of normalized LTV might you anticipate appearing within the portfolio?
Peter Sack
executiveHonestly, that is a tough, that is a tough one; answering it is tough since several factors are involved. My expectation would be that, assuming the reform under discussion turns out to be rescheduling. I have not observed instances where a meaningful number of additional lenders came into the market when rescheduling happened; therefore I believe there is a chance to grow our loan sizes across many situations with numerous borrowers, driven by better cash flow dynamics for operators within a rescheduling setting, given that 280E taxes would no longer have an impact. That is one factor behind why loan balances could rise in a world after rescheduling, since the underlying cash flow profile for the industry as well as for individual operators has gotten substantially better. Yet conversely, I would also anticipate far greater equity interest flowing into the sector because of rescheduling. Consequently, I would anticipate the denominator, meaning the V within that ratio, rising substantially, beginning with public operators and public cannabis valuations; combining these two things is hard; figuring out precisely what the shift in LTV would be is hard.
Chris Muller
analystUnderstood. There are still plenty of unknowns out there, so that makes complete sense.
Peter Sack
executiveRight. Still, I want to point something out. When we underwrite, our attention goes to whether a cannabis operator can handle its debt obligations and repay what it owes. That was what mattered to us back when cannabis companies carried valuations in the high teens EV to EBITDA, and it remains what matters now that those companies carry valuations in the single-digit EV to EBITDA range. So for that reason, grasping the cash flow, how varied those cash flows are, and the collateral involved is truly essential for us — more essential than a market cap that might prove fleeting, or a license value that might prove fleeting.
Chris Muller
analystUnderstood. All of that is extremely useful, and I suppose I just have one quick point of clarification, if I may. Did I understand you correctly stating that, right now as we speak, active floors are in place across 86% of the portfolio?
Peter Sack
executiveThat figure reflects both floors and fixed rate.
Chris Muller
analystUnderstood. Okay, those were every question I had. Many thanks.
David Kite
executiveThanks, Chris.
Pablo Zuanic
analystThanks, and hello to all of you this morning. Peter, I get that no two businesses are alike. Still, take IIPR, which this morning said it was making an investment outside cannabis. Then there's AFC Gamma, which is shifting into a BDC and putting money outside cannabis. Chicago Atlantic BDC is also placing capital outside cannabis. So, considering the cannabis landscape, might Chicago Atlantic Real Estate Finance look into doing the same thing?
Peter Sack
executiveThere are times when we've put money to work beyond cannabis. Even so, what we've observed is that for loans backed by real estate within cannabis, the balance of risk against reward looks far more appealing — in the majority of situations — than what you'd see with comparable loans tied to real estate in non-cannabis properties. That is exactly why our attention, and by far the largest share of the portfolio in REFI, goes toward cannabis deals. Should that shift, though — should we come across attractive opportunities backed by real estate — we would absolutely bring them to REFI and might put capital to work there. Even so, Chicago Atlantic came into being centered on idiosyncratic and niche corners of private credit, and centered on cannabis too; that sits within our DNA. Nor will that cannabis emphasis and our loyalty to the sector shift. In my view, this helps explain why we've stayed the course in this industry and keep deploying into it while equity markets have gone through dramatic swings and other lenders have left the space. Our belief is that such concentration and specialization can generate exceptional returns — truly differentiated ones — for those who invest with us, and that we're able to deliver a superior product, superior support, and a superior relationship with our clients and our borrowers. Moreover, we've seen that showing up consistently in the market and giving borrowers consistent backing produces stronger relationships, longer-lasting relationships, and a greater capacity on our part to forge ties with the next leading operator to come out of the ecosystem.
Pablo Zuanic
analystOkay, that’s a good question. Thanks. Moving on to 280E — in the earlier question, you said your primary concern is whether a company can handle its debt payments, correct? So how do you take into account the uncertain tax provision that the vast majority of MSOs carry? Most of them — actually, not most, nearly every one except a single company — are filing and paying taxes like an ordinary corporation, and they’re assuming 280E doesn’t apply; and following guidance and recommendations from lawyers and auditors, they’re recording something known as an uncertain tax provision or benefit as a long-term liability, right? We’ll only find out if it ever comes due, and it has no maturity date. But how do you incorporate that into your assessment of debt-service capacity?
Peter Sack
executiveWe view this as an additional type of leverage. Therefore, our goal is to establish covenants that restrict what our borrowers can do when it comes to taking on uncertain tax liabilities beyond a specific threshold. That threshold gets determined by how comfortable we are with the company's overall leverage profile.
Pablo Zuanic
analystAll right, no, that's fine. Thanks. See, I realize we typically avoid discussing individual borrowers, but Verano came up in your prepared remarks. I'm attempting to grasp the mechanics here; regarding Verano, Chicago Atlantic, I think collectively, not merely REFI, holds a facility of roughly $300 million, with a book of $292 million in Verano maturing next year, correct? And now you've put out this revolver of $75 million, a three-year revolver. I'm attempting to grasp the mechanics regarding why you wouldn't simply restructure everything and just restructure that $300 million loan maturing next year. Or since we don't know what reform will bring, you might just — I'm simply attempting to grasp why not do that instead of putting out a short-term three-year revolver here.
Peter Sack
executiveOur admiration for the Verano team is enormous—for everything they've achieved, for what they're delivering right now, and for the growth they have ahead. Their geographic reach, the assets they hold, and the way they think about this industry strike us as genuinely distinctive in this sector. That partnership means a great deal to us. So wherever we're able to lend a hand, we'll be prepared and eager to do so, and we'll give our utmost to advance their upcoming expansion efforts—and the same holds true across the remainder of our portfolio. I won't presume to describe what their objectives are or how they'd prefer to arrange their balance sheet. What I will say is that we treasure the relationship and the partnership, we'd be delighted to help in whatever manner we can, and we're truly enthusiastic about what they're delivering across their portfolio.
Pablo Zuanic
analystAlright, and I’d like to squeeze in one final question if that’s okay. We’ve talked in the past about rivals coming from different industries, I realize that. Not long ago, I attended the Blank Rome Conference. At that event, Needham Bank stated they had made roughly $500 million worth of loans within the cannabis space, and Curaleaf was among the most recent recipients. According to them, reaching $2 billion will never happen, yet they suggested the present figure might be doubled. So from what I gather, with regulations as they stand now, regional banks like Valley Bank, Needham, or others are stepping up their competitive pressure. Peter, is my interpretation incorrect?
Peter Sack
executiveI believe that the banks which built up know-how, put money into infrastructure, and put money into relationships within the cannabis sector, on the whole, those banks have performed well, since they allocated capital with discipline and prudence and formed ties with a number of the strongest operators in the sector, and often, those banks now choose to go further in because they have witnessed and lived through success, and so I believe we are — I believe we have observed that among a number of the biggest banks that have steadily allocated capital in the sector, they are looking to do additional business, and that is excellent. We regard banks as allies in how we deploy. There are providers of leverage in our public funds as well as our private funds. There are lenders alongside us in a lot of deals. There are lenders alongside us in our deals across a lot of deals, and so we consider them a vital component of the lending ecosystem, and they play a role in this effort to construct mature capital markets for the cannabis sector, and I think, just by way of comparing where the banking sector stands inside the wider private credit ecosystem at present. Banks are not apart from the cannabis sector. Banks are participants right next to the private credit arena, and the private credit arena, be it mortgage REITs or BDCs, functions right next to the banking ecosystem, and they gain from each other considerably and cooperate as a component of this ecosystem, and that is what we are hoping to watch emerge in the cannabis sector, and that is what we are attempting to construct at Chicago Atlantic via our assorted partnerships with almost every one of the major banks that operate in the cannabis sector at present, so to put it briefly, we welcome and have labored to assist banking institutions in entering the cannabis sector, and we hope additional ones will do so.
Pablo Zuanic
analystMy apologies. If it's alright, I'd like to squeeze in an additional question. And I apologize if another person is waiting in the queue. Could you provide an update regarding the lending initiative for New York? My understanding is that the loan goes to a regulator, correct? It isn't necessarily made to a fund; those aren't necessarily made to the stores. I believe we've reached 251 stores. Clearly, the state keeps growing when it comes to retail stores, yet I haven't really seen that show up in your loan book, or perhaps I'm overlooking something; but if you could give an update on this, thank you.
Peter Sack
executivePablo, I apologize — I couldn't catch the start of what you asked. Would you mind saying it again?
Pablo Zuanic
analystAlright, let me say that again. What I'm referring to is New York State. When it comes to how many shops and dispensaries exist there, that figure keeps rising. I believe we're past 250 at this point. And my thinking was that because of the arrangement you have with the regulator in that state regarding the funding — the fund over there — your lending into the program ought to have gone up as more stores opened. Yet that doesn't appear to show up in your loan book. Unless I'm overlooking something; and I apologize if the connection is poor.
Peter Sack
executiveNo, thank you. The New York Social Equity Fund has chosen against pulling more capital from our funds. They have backed the building of roughly 23 stores throughout the state. And they have hit pause on deployments. With that said, we stand ready and willing to assist them should they choose to keep deploying and keep expanding the store portfolio they are backing.
Pablo Zuanic
analystUnderstood. I appreciate it.
Peter Sack
executiveThanks, everyone, for the backing and for what you asked. Happy to continue any discussions after this call, so don't hesitate to get in touch whenever you like. Once more, many thanks.
Operator
operatorThat brings this call to a close. We appreciate your joining us for today's presentation. You're free to disconnect at this time.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chicago Atlantic Real Estate Finance, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Chicago Atlantic Real Estate Finance, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chicago Atlantic Real Estate Finance, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.